Colchicine and mortality outcomes in patients with coronavirus disease (COVID-19).

Danjuma, Mohammed I; Kaul, Ridhima; Alyaarabi, Tamader; Elsayed, Basant; Elshafei, Mohamed

Danjuma, Mohammed I; Kaul, Ridhima; Alyaarabi, Tamader; Elsayed, Basant; Elshafei, Mohamed.

Danjuma MI; Department of Internal Medicine, Hamad Medical Corporation, Doha Qatar; Department of Internal Medicine, Weill Cornell College of Medicine, New York, and Doha Qatar. Electronic address: mdanjuma@hamad.qa.
Kaul R; Department of Internal Medicine, Weill Cornell College of Medicine, New York, and Doha Qatar.
Alyaarabi T; Department of Internal Medicine, Qatar University College of Medicine.
Elsayed B; Department of Internal Medicine, Qatar University College of Medicine.
Elshafei M; Department of Pharmacy, Hamad Medical Corporation, Doha Qatar.

Eur J Intern Med ; 112: 126-127, 2023 Jun.

Artículo en Inglés | MEDLINE | ID: covidwho-2240083

Asunto(s)

COVID-19; Colchicina; Humanos; Colchicina/uso terapéutico; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Colchicina / COVID-19 Límite: Humanos Idioma: Inglés Revista: Eur J Intern Med Asunto de la revista: Medicina Interna Año: 2023 Tipo del documento: Artículo

Similares

MEDLINE

LILACS

LIS

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google